Results 241 to 250 of about 18,764 (290)

Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer. [PDF]

Front Immunol
Chen YC, Figueiredo ML.
europepmc   +1 more source

Editorial: Advancements in feline oncology: diagnosis, treatment, and management of domestic cat cancers. [PDF]

Front Vet Sci
Horta RDS, Giuliano A, da Costa FVA.
europepmc   +1 more source

Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment. [PDF]

Front Immunol
Jennings VA, Rumbold-Hall R, Migneco G, Barr T, Reilly K, Ingram N, Hilare IS, Heaton S, Alzamel N, Jackson D, Ralph C, Banerjee S, McNeish I, Bell JC, Melcher AA, Ilkow C, Cook GP, Errington-Mais F.   +17 more
europepmc   +1 more source

A NOVEL APPROACH OF VIROTHERAPY BASED HSF-1 shRNA IN CANCER ERADICATION

, 2013
I Gede Putu Supadmanaba, I. B. T. Wibawa-Manuaba   +1 more
openalex   +1 more source

A Comprehensive Review of Modern Cancer Therapies Utilizing Oncolytic Viruses. [PDF]

Cells
Sułek M, Szuster-Ciesielska A.
europepmc   +1 more source

Oncolytic Virotherapy for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical and Research Strategies. [PDF]

J Multidiscip Healthc
Liu S, Liang R.
europepmc   +1 more source

Oncolytic virus VG161 offers new hope for refractory liver cancer. [PDF]

Front Oncol
Li J, Zhou H, Wang X, Huang K, Wang Y.
europepmc   +1 more source

Oncolytic HSV-1 expressing GM-CSF and IL-12 enhances anti-tumor efficacy in immunocompetent murine melanoma model. [PDF]

Virol Sin
Xiao H, Yin Q, Liu J, Hu H, Li J, Wang M, Hu Z.   +6 more
europepmc   +1 more source

Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. [PDF]

Cancer Immunol Immunother
Pakola SA, Ojala N, Kudling TV, Clubb JHA, Jirovec E, van der Heijden M, Arias V, Haybout L, Basnet S, Grönberg-Vähä-Koskela S, Quixabeira DCA, Santos JM, Cervera-Carrascon V, Hemminki O, Kanerva A, Mustonen H, Puolakkainen P, Seppänen H, Hemminki A.   +18 more
europepmc   +1 more source

Viral warriors: Unlocking the immune system's potential with oncolytic viruses in cancer immunotherapy. [PDF]

Mol Ther Oncol
Ghavimi R, Rahimian L, Mohammadi M, Dutta O, Mohan H, Chouljenko V, Omolekan TO, Chamcheu JC, Kousoulas KG.   +8 more
europepmc   +1 more source